プレスリリース

Illumina To Webcast Upcoming Investor Conference

SAN DIEGO, Feb. 27, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:

  • 43rd Annual Cowen Health Care Conference on March 7, 2023
    Fireside chat at 6:50am Pacific Time (9:50am Eastern Time)

The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com.  A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.

About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.

Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com

Media:
David McAlpine
+1.347.327.1336
pr@illumina.com

 

Cision View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conference-301757041.html

SOURCE Illumina, Inc.

最近の記事

ヒトゲノムの暗黒領域に潜む手がかりの探索
ヒトゲノムの暗黒領域に潜む手がかりの探索
精密医療の実現に向けて医療の進歩を支えるイルミナ社員の取り組み
精密医療の実現に向けて医療の進歩を支えるイルミナ社員の取り組み
複雑な卵巣症例における悪性・良性腫瘍の鑑別を支えるマルチオミクス
複雑な卵巣症例における悪性・良性腫瘍の鑑別を支えるマルチオミクス